Stock MOVE MOVANO INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Movano Inc.

Equities

MOVE

US62459M1071

End-of-day quote Nasdaq
Other stock markets
 18:00:00 2024-05-09 EDT 		5-day change 1st Jan Change
0.435 USD +10.15% Intraday chart for Movano Inc. -7.45% -44.33%
05-09 Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision CI
04-17 Movano Inc. announced that it has received $24.128792 million in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision
PR
Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision
CI
Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024
PR
Movano Inc. announced that it has received $24.128792 million in funding
CI
Movano Health Closes $24 Million Private Placement
AQ
Movano Health Closes $24 Million Private Placement
PR
Transcript : Movano Inc., Q4 2023 Earnings Call, Apr 04, 2024
Movano Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Movano Health Reports 2023 Financial Results and Provides Business Update
PR
BestGrowthStocks.Com Issues Comprehensive Evaluation of Movano Inc.
AQ
Movano to Raise $24 Million From Share Placement
MT
Movano Health Announces $24 Million Private Placement
PR
Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company
PR
Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024
PR
Movano Inc. announced that it expects to receive $24.14411 million in funding
CI
Evie Ring's Pulse Oximeter Exceeds FDA Accuracy Guidelines in Movano Health's Second Hypoxia Trial
PR
Movano Health's Evie Ring's Pulse Oximeter Exceeds FDA Accuracy Guidelines in Movano Health's Second Hypoxia Trial
CI
Certain Common Stock of Movano Inc. are subject to a Lock-Up Agreement Ending on 12-FEB-2024.
CI
Certain Warrants of Movano Inc. are subject to a Lock-Up Agreement Ending on 12-FEB-2024.
CI
Certain Options of Movano Inc. are subject to a Lock-Up Agreement Ending on 12-FEB-2024.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MOVE Stock
  4. News Movano Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW